JP2024526944A5 - - Google Patents
Info
- Publication number
- JP2024526944A5 JP2024526944A5 JP2024503869A JP2024503869A JP2024526944A5 JP 2024526944 A5 JP2024526944 A5 JP 2024526944A5 JP 2024503869 A JP2024503869 A JP 2024503869A JP 2024503869 A JP2024503869 A JP 2024503869A JP 2024526944 A5 JP2024526944 A5 JP 2024526944A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- interleukin
- pharmaceutical product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2110721.4 | 2021-07-26 | ||
| GBGB2110721.4A GB202110721D0 (en) | 2021-07-26 | 2021-07-26 | Treatment and prevention of alcoholic liver disease |
| GBGB2110862.6A GB202110862D0 (en) | 2021-07-28 | 2021-07-28 | Treatment and prevention of alcoholic liver disease |
| GB2110862.6 | 2021-07-28 | ||
| PCT/EP2022/070974 WO2023006765A1 (en) | 2021-07-26 | 2022-07-26 | Treatment and prevention of alcoholic liver disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024526944A JP2024526944A (ja) | 2024-07-19 |
| JP2024526944A5 true JP2024526944A5 (cg-RX-API-DMAC7.html) | 2025-07-14 |
Family
ID=83081349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024503869A Pending JP2024526944A (ja) | 2021-07-26 | 2022-07-26 | アルコール性肝疾患の処置および予防 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20250092126A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4376948A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024526944A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023006765A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE318832T1 (de) | 1990-06-11 | 2006-03-15 | Gilead Sciences Inc | Verfahren zur vervendung von nukleinsäureliganden |
| ES2093562B1 (es) | 1995-05-26 | 1997-07-01 | Univ Santiago Compostela | Estabilizacion de sistemas coloidales mediante formacion de complejos ionicos lipido-polisacarido. |
| US6649192B2 (en) | 1996-07-29 | 2003-11-18 | Universidade De Santiago De Compostela | Application of nanoparticles based on hydrophilic polymers as pharmaceutical forms |
| US6506559B1 (en) | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
| CA2237915A1 (en) | 1998-05-19 | 1999-11-19 | Stephen Shaughnessy | Osteoporosis treatment |
| EP1235842A4 (en) | 1999-10-15 | 2003-04-23 | Univ Massachusetts | Rna interference pathway genes as tools for targeted genetic interference |
| CA2703544C (en) | 2007-10-26 | 2016-01-05 | Manuel Baca | Cytokine muteins |
| US8182814B2 (en) | 2007-10-26 | 2012-05-22 | Csl Limited | Methods of treating inflammatory airway conditions by inhibition of IL-11 activity |
| US8518888B2 (en) | 2008-10-14 | 2013-08-27 | Csl Limited | Method of treatment of gastrointestinal-type cancer with antagonistic antibodies to IL-11R |
| PT2953971T (pt) | 2013-02-07 | 2023-05-02 | Csl Ltd | Proteínas de ligação à il-11r e suas utilizações |
| GB201522186D0 (en) | 2015-12-16 | 2016-01-27 | Singapore Health Services Pte Ltd And Nat University Of Singapore The | Treatment of fibrosis |
| GB201621431D0 (en) | 2016-12-16 | 2017-02-01 | Singapore Health Services Pte Ltd And Nat Univ Of Singapore The | Decoy cytokine receptor |
| GB201621439D0 (en) | 2016-12-16 | 2017-02-01 | Singapore Health Services Pte Ltd And Nat Univ Of Singapore | IL-11Ra Antibodies |
| US20180186871A1 (en) | 2016-12-16 | 2018-07-05 | Singapore Health Services Pte Ltd. | Il-11 antibodies |
| GB201809700D0 (en) | 2018-06-13 | 2018-08-01 | Singapore Health Serv Pte Ltd | IL-11 antibodies |
| GB201809699D0 (en) | 2018-06-13 | 2018-08-01 | Singapore Health Serv Pte Ltd | IL-11 antibodies |
| WO2020152122A1 (en) * | 2019-01-21 | 2020-07-30 | Singapore Health Services Pte. Ltd. | Treatment of hepatotoxicity |
| KR20220050087A (ko) * | 2019-05-03 | 2022-04-22 | 싱가포르 헬스 서비시즈 피티이 엘티디 | 대사성 질환의 치료 및 예방 |
-
2022
- 2022-07-26 WO PCT/EP2022/070974 patent/WO2023006765A1/en not_active Ceased
- 2022-07-26 EP EP22760659.7A patent/EP4376948A1/en active Pending
- 2022-07-26 US US18/292,152 patent/US20250092126A1/en active Pending
- 2022-07-26 JP JP2024503869A patent/JP2024526944A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022521591A5 (cg-RX-API-DMAC7.html) | ||
| JP2022531591A5 (cg-RX-API-DMAC7.html) | ||
| Tanaka et al. | Interleukin (IL-6) immunotherapy | |
| Maes et al. | Targeting interleukin-4 in asthma: lost in translation? | |
| Villaescusa et al. | A new approach to the management of COVID-19. Antagonists of IL-6: Siltuximab | |
| JP2020510662A5 (cg-RX-API-DMAC7.html) | ||
| CN112153982A (zh) | 用于通过施用il-4r抑制剂治疗特应性皮炎的方法 | |
| JP2020128375A (ja) | ベンラリツマブを使用して喘息の増悪率を低減する方法 | |
| JP2019534891A5 (cg-RX-API-DMAC7.html) | ||
| JP2010500360A5 (cg-RX-API-DMAC7.html) | ||
| Hirota et al. | Chemically modified interleukin-6 aptamer inhibits development of collagen-induced arthritis in cynomolgus monkeys | |
| Rommasi et al. | Immunomodulatory agents for COVID-19 treatment: possible mechanism of action and immunopathology features | |
| Clark et al. | Potential of anticytokine therapies in central nervous system ischaemia | |
| KR20060023968A (ko) | 중증 급성 호흡기 증후군(sars)의 치료를 위한 조성물및 방법 | |
| AU2019236656A1 (en) | Anti-ccl2 and anti-loxl2 combination therapy for treatment of scleroderma | |
| CN106459971B (zh) | 用于治疗自身免疫性疾病的联合疗法 | |
| JP2013504603A5 (cg-RX-API-DMAC7.html) | ||
| Crockett et al. | Protection of early phase hepatic ischemia-reperfusion injury by cholinergic agonists | |
| US20240024308A1 (en) | Tlr7/8 antagonists for the treatment of coronavirus infections | |
| Nishimoto | Clinical studies in patients with Castleman’s disease, Crohn’s disease, and rheumatoid arthritis in Japan | |
| CN105705518A (zh) | 用于治疗类风湿性关节炎或作为镇痛药的中和gm-csf的抗体 | |
| JP2022518251A5 (cg-RX-API-DMAC7.html) | ||
| JP2022549854A5 (cg-RX-API-DMAC7.html) | ||
| NZ728020A (en) | Anti-il4-il 13 bispecific antibodies | |
| Ramos et al. | Targeting specific immunologic pathways in Crohn's disease |